Pre-Operative Pregabalin for Post-Operative Pain in Head and Neck Cancer Surgery
Status:
Withdrawn
Trial end date:
2020-07-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate and reduce pain and improve quality of life in
patients being treated for head and neck cancer with primary tumor resection and bilateral
neck dissections. Patients will be randomly assigned to receive either pre-operative
pregabalin (Lyrica) or a placebo. Patients and investigators will be blinded to which
medication patients receive, and all patients will receive the same postoperative pain
medication regimen with appropriate pain treatment as needed. Patients will be asked to fill
out surveys prior to surgery, while in the hospital after surgery, and at each follow-up
appointment for up to 24 months.